Antenatal glucocorticoids are used to promote the maturation of fetuses at risk for preterm delivery. While perinatal glucocorticoid exposure has clear immediate benefits to cardiorespiratory function, there is emerging evidence of adverse long-term effects. To determine if antenatal betamethasone alters vascular reactivity, we examined isometric contraction of endothelium-intact coronary and mesenteric arteries isolated from twin fetal sheep at 121-124 days gestation (term being 145 days). One twin received betamethasone (10 µg/h iv) while the second twin received vehicle (0.9% NaCl) for 48 hours immediately prior to the final physiological measurements and tissue harvesting. Fetuses that received betamethasone had higher mean arterial blood pressures than the saline-treated twin controls (53 ± 1 vs. 48 ± 1mmHg, P < 0.05). Coronary vessels from betamethasone-treated fetuses exhibited enhanced peak responses to angiotensin II (ANG II) (72 ± 17% vs. 23 ± 6% of the maximal response to 120mM KCl, P < 0.05). There was no significant difference in response of the coronary arteries to other vasoactive compounds (KCl, U46619, sodium nitroprusside, 8-Br-cGMP, isoproterenol, and forskolin). Contractile responses to ANG II were similar in betamethasone and control mesenteric arteries (48 ± 17% vs. 36 ± 12% of the maximal response to 10 -6 M U46619).
INTRODUCTION
Consensus statements now widely support the routine administration of antenatal corticosteroids to mothers at risk of preterm delivery between 24 and 34 weeks gestation (1, 32) . Since the pioneering work of Liggins and Howie in 1972, a multitude of well-designed studies have shown antenatal corticosteroid administration significantly reduces mortality, respiratory distress syndrome and intraventricular hemorrhage in preterm infants (7, 18) . In the 1990s, multiple courses of corticosteroids were used in an attempt to maximize fetal health (31). However, recent research has identified progressive growth restriction with repetitive doses (12, 16) .
Potential adverse effects from a single course of therapy during the late stages of development are now emerging (17, 22, 27) .
In animal models, acute glucocorticoid exposure elevates the blood pressure of late gestation fetuses, and ovine small femoral arteries have shown enhanced vasoconstriction to potassium chloride and endothelin-1 immediately following steroid administration (2, 9, 10).
Paradoxically, steroid administration has also been associated with enhanced endotheliumdependent vasodilatation to acetylcholine (2) . Finally, acute corticosteroid exposure has been associated with increased coronary artery relaxation to bradykinin and nitric oxide, potentially related to increased guanylate cyclase activity (13) . The purpose of our study was to clarify whether antenatal glucocorticoid administration alters coronary and mesenteric artery vascular reactivity and to investigate possible mechanisms regulating these effects.
METHODS
Tissue collection. All procedures were performed within the regulations of the Animal Welfare Act and the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the University of Iowa Animal Care and Use Committee. Time-dated pregnant ewes with twins at 116-119 days gestation (term being 145 days) were obtained from a local source (n = 5). Ewes were anesthetized with 12 mg/kg of thiopental sodium (Abbott Laboratories, Abbott Park, IL), intubated and ventilated with a mixture of halothane (1%), oxygen (33%) and nitrous oxide (66%). After performing an abdominal flank incision, the uterus was partially externalized and opened over the fetal hindlimbs. Polyethylene catheters were inserted into a femoral artery and vein, and a catheter immersed in amniotic fluid was sutured to the fetal skin. The fetal incisions and uterine openings were closed, and the procedure was repeated for the second twin. All the catheters were exteriorized through a subcutaneous tunnel into a cloth pouch on the ewe's flank. Ampicillin (Sigma, St. Louis, MO) was administered at the completion of surgery (2 g intra-amniotic and 2 g intramuscular to the ewe), followed by intramuscular injections (1 g ) to the ewe every 12 hours for 3 days. After surgery, the ewe was returned to an individual pen and allowed free access to food and water.
After a 3-day recovery period, one fetus received betamethasone (10 µg per hour by continuous intravenous infusion over 48 hours; Schering, Kenilworth, NJ) while the control twin received an identical volume of vehicle (0.9% NaCl). The dose and route utilized corresponds to the those used by other investigators to ensure consistent corticosteroid exposure (2) , while the use of twin controls was chosen to minimize potentially confounding environmental conditions, such as maternal health and diet. The virtual absence of vascular anastomoses between twin placentae in sheep, coupled with the larger volume of distribution seen in the pregnant ewe compared to the exposed fetus, assured selective administration to a single fetus (20) . Before and after the 48-hour infusion, arterial blood gases and chemistries were sampled using a pH/blood gas/electrolyte analyzer (IL 1640, Instrumentation Laboratory, Milano, Italy), and arterial blood pressure and heart rate were recorded over a one-hour time period, using MacLab software (ADInstruments, Colorado Springs, CO). Immediately following the 48-hour infusion, at 121-124 days gestation, maternal anesthesia was then reinduced and maintained as previously outlined. Fetuses were delivered by cesarean section and euthanized with intravenous pentobarbital sodium (50mg/kg; Abbott Laboratories, Abbott Park, IL). Coronary and secondgeneration mesenteric arteries were than collected. Artery segments, from which residual blood was expressed and loosely adherent connective tissue removed, were quickly placed in ice-cold, bicarbonate-buffered physiological salt solution (PSS), 4% paraformaldehyde or snap frozen in liquid nitrogen.
Isolated vessel contractile responses. Circumflex coronary artery segments were cleansed of adherent connective tissue and sectioned into 3 mm rings on the day of collection. The secondgeneration mesenteric arteries were stored in chilled (4˚C) bicarbonate-buffered PSS overnight, prior to sectioning into 4 mm rings. The endothelium was left intact and the rings were mounted in individual 18 ml isolated organ chambers and connected to an isometric force transducer by 32-gauge stainless steel wire. Contractile responses were recorded with an eight-channel MacLab 8E and stored on a Power Macintosh 8600 computer. The length-tension relationship was defined experimentally to 30 and 90 mM KCl at varying passive stretch. Passive stretch was set at 90% of the tension required to obtain peak responses to KCl (0.7 g for both coronary and mesenteric arteries), and the rings were allowed to equilibrate in PSS at 37˚C for 60 min before the start of experimentation. PSS was aerated with a mixture of 95% O 2 -5% CO 2 
Data analysis.
Comparison of physiologic parameters was made using two-way analysis of variance, factoring for treatment group and timing in relation to infusion. If the overall analysis of variance identified significant differences (P < 0.05), pairwise comparisons were made using Tukey's procedure, with P < 0.05 considered significant. Vascular responses and protein expression were compared using Student's unpaired, two-tailed t-test (with significance at P < 0.05). All analyses were performed using SigmaStat 3.0 for Windows (SPSS Inc., Chicago, IL).
All values are presented as mean ± SE, and n refers to the number of animals studied.
RESULTS
Physiologic Parameters. Fetal mean arterial blood pressure was similar between the groups prior to betamethasone administration ( Table 1) . The mean arterial blood pressure was higher in the betamethasone-treated than the saline-treated fetuses following the 48-hour infusion (53 ± 1
vs. 48 ± 1 mmHg, P < 0.05). There were no significant differences in weight, heart rate, hematocrit, arterial blood gas values or electrolytes between or within either group.
Vascular Reactivity. The maximal vasoconstrictive responses of coronary artery segments to 120mM KCl and 10 -6 M U46619 were not significantly altered by betamethasone infusion, while the maximal responses of mesenteric artery segments to 120mM KCl was significantly decreased following betamethasone infusion ( Table 2 ). The dose-response curves for vasoconstriction to increasing concentrations of KCl were similar in betamethasone-infused and saline-infused coronary arteries ( Figure 1A ). Although the steroid-exposed coronary arteries achieved significantly more vasodilatation to low concentrations of acetylcholine (P < 0.05 vs. control), the vasoconstriction seen at higher concentrations was not significantly different between groups ( Figure 1B ). The maximal contractile response to angiotensin II was significantly increased in the coronary arteries of the betamethasone-infused versus the saline-infused animals (72 ± 17%
vs. 23 ± 6% of the response to 120mM KCl, P < 0.05). However, contractile responses to ANG II were similar in betamethasone and control mesenteric arteries (48 ± 17% vs. 36 ± 12% of the maximal response to 10 -6 M U46619). Marked tachyphylaxis to increasing concentrations of ANG II was noted in both coronary and mesenteric arteries ( Figures 1C and 1D , respectively).
Fetal mesenteric arteries from the betamethasone-exposed group were significantly less responsive to graded concentrations of KCl than their saline-exposed counterparts ( Figure 2A , P < 0.05). There were no statistically significant intergroup differences in vasoconstriction to phenylephrine between the mesenteric arteries ( Figure 2B ). Responses in the betamethasoneexposed group tended to be reduced, but these responses in general were highly variable.
Coronary arteries were completely unresponsive to phenylephrine at concentrations up to 10 -4 M (data not shown).
No between-group differences were detected in the coronary vasodilatory responses elicited by was upregulated by betamethasone infusion in coronary arteries (P < 0.05 vs. control), but not in mesenteric vessels ( Figure 5B ). There was no difference in AT 2 receptor protein expression following betamethasone infusion in either the coronary or mesenteric arteries ( Figure 6B ). AT 1 protein expression was greater in coronary arteries than mesenteric arteries, in contrast to AT 2 protein expression, which was greater in the mesenteric arteries ( Figures 5B and 6B ).
The immunoblots probed with the eNOS antibody showed the major band at 140 kDa ( Figure 7 ).
The increase in eNOS expression following betamethasone infusion did not reach statistical significance in either the coronary or mesenteric arteries (P = 0.12 and P = 0.14, respectively). While the betamethasone-exposed coronary arteries initially dilated following acetylcholine activation of endothelial nitric oxide synthase, activation of the muscarinic receptors present within the vascular smooth muscle presumably resulted in overriding vasoconstriction, again involving the activation of phospholipase C. The propensity of coronary arteries to constrict to high concentrations of acetylcholine has been described, and the propensity of vessels exposed to betamethasone to constrict more intensely parallels the results seen by Docherty et al. in cerebral arteries (9, 45) . These differences may be a subtle sign of early endothelial dysfunction resulting in overriding vasoconstriction. The ability of ANG II to affect such dysfunction through activation of plasma membrane-bound NADPH oxidase and subsequent production of reactive oxygen species deserves further consideration (14, 46) .
Reminiscent of the coronary artery dilatory response to acetylcholine seen only in the steroidexposed group, the betamethasone-exposed mesenteric arteries displayed significantly enhanced vasodilation to acetylcholine. These results mirror those seen by both Anwar and Molnar in ovine femoral arteries following steroid exposure (2, 21) . In the face of accentuated endothelialdependent vasodilation to acetylcholine following betamethasone exposure, the attenuated response of the same mesenteric arteries to a nitric oxide donor, sodium nitroprusside, raises the possibility that endothelial nitric oxide synthase activity was enhanced following steroid administration. Immunoblots subsequently showed a consistent trend towards increased eNOS expression following steroid-exposure in both the mesenteric and coronary arteries, although the results did not reach statistical significance. This finding is intriguing given the well described protective effect of antenatal corticosteroids on the development of necrotizing enterocolitis, a condition often associated with mesenteric ischemia (7) . Highlighting the vessel specific alterations often seen in vascular research, eNOS expression has been shown to be down-regulated in rat aorta and unchanged in ovine femoral arteries following dexamethasone administration (21, 44) .
Unlike the results reported by Anwar el al. (2) showing attenuated femoral artery vasodilation to forskolin following exposure to betamethasone, we found no difference in coronary or mesenteric artery responsiveness to adenylate cyclase activation. Isoproterenol, a beta-agonist that mediates vasodilatation through G-protein coupled activation of adenylate cyclase, and forskolin, a direct activator of adenylate cyclase, produced similar dose-response relationships.
These apparently contradictory results again stress the importance of vessel-specific research and highlight the possibility that the pathway connecting corticosteroids and hypertension may be different than that linking antenatal corticosteroid exposure and coronary artery disease. In fact, 
Perspectives
There is increasing interest regarding the nonpulmonary effects of glucocorticoid exposure to the fetus. Maternal glucocorticoid administration lessens the incidence of complications associated with prematurity. However, a number of studies have indicated prenatal glucocorticoid exposure may lead to permanent effects on cardiovascular homeostasis (11, 28) . In the present study, the Table 1 . Physiologic parameters for ovine fetuses before and after 48-hour continuous intravenous infusion of saline or betamethasone. Values are displayed as means ± SE; n = 5. *Significantly different from control value at P < 0.05.
